Identification of ALK and ROS1 fusion proteins in non-small cell lung cancer (NSCLC) at Cell Signaling Technology (CST).
Cancer signaling pathways and research resources, including activation state antibodies and proteomic tools to discover post-translational modifications
Immunohistochemistry Protocol (Paraffin): easy to follow directions describing the step by step experimental procedure.
Expert-reviewed interactive pathway providing a current overview of ErbB/HER Signaling, a pathway description, select PubMed references, and links to PhosphoSitePlus.
A list of recommended cell types and treatments to be used as positive and negative controls for activation state specific antibodies
PTMScan Technology enables biomarker discovery and signaling regulation by combining enrichment of post-translational modifications with mass spectrometry.
Kinase-disease associations table showing kinases, kinase groups, disease types, and the molecular biology basis for disease.
List of publications based on primary research done by the Cancer Research Group at CST (2002-2013).
Listing of IHC-related scientific posters and papers involving scientists from Cell Signaling Technology.
A list of important CD markers that includes links to PhosphoSitePlus, Uniprot, and products from Cell Signaling Technology.
